Makeda Semret

Associate Professor of Medicine @McGillU; Infectious diseases and medical microbiology, Antimicrobial stewardship; Ethio-Canadian, views my own

[Makeda Semret @MSemret]

@avideh_afshar @ABsteward Aha!

[MI4 @MI4Innovates]

We were part of the Dream! 💫
The MI4 team joined the MUHC Foundation’s Dream Big Celebration on June 11—celebrating $203M raised to supercharge research and improve care.
That’s a dream come true. 🌟
@MSemret
@MUHCFoundation
#DreamBigMUHC #MI4McGill #ResearchMatters #Health

[AMR Centre @McGillAMRCentre]

Our Annual AMR Symposium will be taking place on Thursday June 5th! Come hear from Man-Wah Tan our keynote speaker and enjoy faculty short talks, trainee flash talks and poster presentations! There will also be a career insight lunch for trainees and a networking reception

[Marcel Behr @mbehr_mcgill]

Congratulations to our colleagues in Infectious Diseases with 4 FRQ awards. @DrToddLee @GBL_Unit and Drs. Lawandi & Costiniuk (not on Twitter-X)

[Makeda Semret @MSemret]

please note Cefazolin simply not available in many LMICs, particularly in subsaharan africa and that's what drives use of ASPs there rather than pure dogma

[Todd C. Lee @DrToddLee]

@BrentFooter @BradSpellberg @ABsteward @Josh_S_Davis @syctong A ton of people have been using ASPs as first line.

[Makeda Semret @MSemret]

@tinsaetigist 👏👏👏

[Sébastien Poulin @sebpoule]

🔥 Big news for TB preventive therapy !

Thanks to 🇨🇦 (😉 🇺🇸), McGill university and Dr Dick Menzies

➡️ New versions TSTin4D (https://t.co/12yZ0XJVys) or IGRAin4D (https://t.co/VjXduxHJkD)

#IDXposts

[Makeda Semret @MSemret]

@mbehr_mcgill congratulations Sarah!

[Makeda Semret @MSemret]

wetting a toe (or a wing?), you can find me @makedasemret.bsky.social
to check out IDSky, 🙏🏽@GermHunterMD for the starter packs!

[Makeda Semret @MSemret]

and also 🙏🏽 @diasoringroup for in-kind support

[Makeda Semret @MSemret]

Again huge 🙏🏽 to @CIHR for funding this trial to start very soon @cusm_muhc @RIMUHC1
with colleagues @AlexLawandi @DonaldVinh @LorneSchweitzer @NandiniDenduku1 and others not on X D.Nguyen, S.Qureshi, P.Lawler, J.Zaharatos, F.Bourdeau et al) -exciting times!

[CIHR @CIHR_IRSC]

Antimicrobial resistance (AMR) is when microbes change so that drugs that previously worked don’t anymore. Antibiotic misuse is the leading cause of AMR. Dr. Makeda Semret is testing a new tool to address this.

Learn more: https://t.co/Cr9xUeRoeF

#WAAW #OneHealth @MSemret

[Makeda Semret @MSemret]

join us @mcgillu @cusm_muhc @McGillTropMed @McGillAMRCentre for what promises to be insightful discussions on the role of diagnostics in containing AMR, from a gifted former ID-Micro clinician turned visionary industry exec!

[AMR Centre @McGillAMRCentre]

Join us on November 21st for a WAAW week special Seminar + Social with a talk by Dr. Mark Miller. Registration is required, please sign up using the QR code or at https://t.co/aOiyJ2kDNq

[Makeda Semret @MSemret]

@ABsteward so sorry for your loss, condolences.

[Makeda Semret @MSemret]

@avideh_afshar, just days after the well researched rounds you gave on this topic!

[Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship]

🔍👁️ 🍄 “Based on available evidence, and high risk of morbidity of eye involvement, continued ophthalmological screens seem prudent, but a definitive consensus was found to be challenging given a lack of outcome data. Additional investigations are warranted. Ophthalmology screenings have a higher sensitivity at >7 days from positive blood culture.”

https://t.co/Qh79beMSOo in @OFIDJournal #IDxPosts

[Makeda Semret @MSemret]

@LussiD il est retraité, non?

[Makeda Semret @MSemret]

@LorneSchweitzer 😂😂

[Makeda Semret @MSemret]

Bravo Herman and colleagues including Dao Nguyen from @McGillAMRCentre for leading this massive initiative, looking forward to contributing!

[CIHR @CIHR_IRSC]

Dr. Herman Barkema @UCalgary will lead a training platform to help future health research leaders apply #OneHealth approaches to the fight against antimicrobial resistance—a growing health threat in Canada and abroad.

https://t.co/7qAf4DvJke

[Makeda Semret @MSemret]

@RIMUHC1 @sapir_ruth @CIHR_IRSC @McGill_TB @cusm_muhc @McGillMed Looking forward to working on this trial (BAST-ICU) with fantastic team from @MI4Innovates and @McGillAMRCentre, and deep 🙏🏽 to @CIHR_IRSC! more to come on this..

[Research Institute of the MUHC (The Institute) @RIMUHC1]

Patrick Lawler, Dick Menzies, Ruth Sapir-Pichhadze @sapir_ruth, and Makeda Semret @MSemret earn > $11 million from @CIHR_IRSC! Félicitations et merci pour votre dévouement en matière des essais cliniques !
https://t.co/KlyPWumSle
@McGill_TB @cusm_muhc @McGillMed

[Makeda Semret @MSemret]

@nemozen @DanielsonKassa1 he just forgot the m